Trial Profile
A retrospective study to investigate the efficacy and safety of Rituximab in patient with severe relapsing granulomatosis with polyangiitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Granulomatosis
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record